Want more from Sunday TODAY? Catch up on our interviews and features here

Closed Captioning
apply | reset x
font
size
T
T
T
T
color

August 26th, 2016

EpiPen’s high price due to ‘broken’ health system, CEO Heather Bresch says

Heather Bresch, CEO of the Mylan pharmaceutical company, says she blames a broken healthcare system for the skyrocketing price of EpiPens. In the wake of growing backlash, the company says the company will offer coupons and financial assistance to purchase the injectors. But some lawmakers dismiss it as a PR move. NBC’s Kristen Welker reports for TODAY from Washington, D.C.

More video

TRENDING

LIFESTYLE